(Q56481671)

English

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis (English)

0 references

0 references

0 references

1 reference

1

Henry R. Kranzler

0 references

author name string

Jeffrey Kirk

series ordinal

2

0 references

publication date

September 2001

0 references

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Alcoholism: Clinical and Experimental Research

0 references

volume

25

0 references

issue

9

0 references

page(s)

1335-1341

0 references

cites work

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02356.X

retrieved

21 January 2018

Pharmacological treatment of alcohol dependence: a review of the evidence

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02356.X

retrieved

21 January 2018

Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02356.X

retrieved

21 January 2018

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02356.X

retrieved

21 January 2018

Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02356.X

retrieved

21 January 2018

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02356.X

retrieved

21 January 2018

New drug treatments for alcohol problems: a critical appraisal

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02356.X

retrieved

21 January 2018

Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02356.X

retrieved

21 January 2018

Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02356.X

retrieved

21 January 2018

Anxiogenic effects of caffeine in patients with anxiety disorders

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02356.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1530-0277.2001.TB02356.X

0 references

(Q56481671)

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)